Long-Term Use of Silybum marianum fruit extract Contributes to Homeostasis in Acne-Prone Skin—A 12 Month Follow-Up International “Real Life” Cohort Study

Jean-Hilaire Saurat, Pascal Reygagne, Gwendal Josse, Zhorha Hamidou, Sophie Bianovici, Francoise Ramel, Elizabeth Durbise, Chiara Lovati, Eleonora Bellani, Dorota Bystrzanowska, Ewa Chlebus, Elzbieta Kowalska-Oledzka, Guillaume D’Auzers, et al

Journal of Personalized Medicine

2022

This open, real-life, year-long multicentre study confirms a previous 48-week proof of concept study and qualifies the use of S. marianum fruit extract as a “field-dermo cosmetic” contributing to homeostasis of acne-prone skin in association with acne drugs.

Acne

Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris

DUCRAY

C. Mias, M.D. Thouvenin, E. Gravier, S. Dalmon, K. Bouyer, S. Alvarez, V. Mengeaud, V. Ribet, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

View publication

Acne
Pediatrics

Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway

DUCRAY

C. Mias, V. Mengeaud, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

View publication

Acne
Pediatrics

Myrtus communis and Celastrol enriched plant cell culture extracts control together the pivotal role of Cutibacterium acnes and inflammatory pathways in acne

DUCRAY

C. Mias, N. Chansard, M. Maitre, M.F. Galliano, L. Garidou, V. Mengeaud, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

View publication

Publication Summary

Long-Term Use of Silybum marianum fruit extract Contributes to Homeostasis in Acne-Prone Skin—A 12 Month Follow-Up International “Real Life” Cohort Study

Our other publications on this subject

Want to read on?

Want to read on?